Answers are grounded in this paper and cite their sources.
Diabetes is a group of metabolic disorder, characterized by increase in the level of glucose, resulting from defects in insulin secretion, its action or sometimes both.The effects associated are prolonged organ damage, dysfunction of especially the eyes, kidneys, nerves, heart, and blood vessels or at times even multiple organ failure.Oral medications may be prescribed, but they are associated with many side effects.Condiments, herbs, various spices and other plant products are considered to be safer in the treatment of diabetes.A commonly used spice is cumin, which is used in the present study to modulate the in vitro glucosidase inhibitory activity of hydroacetone extract of spice and its antidiabetic potential.The spice was also studied for its enzyme inhibitory activity post nanoencapsulation and for herb-drug (acarbose) intera ction.The IC 50 value of Cumin.Cyminum L. extract for -glucosidase inhibitory activity, was found to be 122.83µg/ml while that of nanoencapsulated extract was 90.965 µg/ml, indicating that nanoencapsulation enhances enzyme inhibitory activity.Herb-drug interaction of nanoencapsulated C.cyminum extract along with acarbose, was also explored.A gradual increase in % -glucosidase inhibitory activity from 27.36 ± 1.45% at T 0 to 93.67 ± 0.21% at T 360 was observed indicating a 2.4% increase over a period of 6 h, suggestive of sustained release and prolonged enzyme activity.The results, thus depict that Cuminum cyminum L. can be a potent candidate for managing blood glucose levels in the diabetic patients by delaying the -glucosidase activity.
No takes yet. Share an insight, caveat, or question.
Ghalib et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: